Literature DB >> 22587482

Valproate-induced hyperammonemic encephalopathy: a brief review.

Chandani Lewis1, Abhishek Deshpande, George E Tesar, Roman Dale.   

Abstract

BACKGROUND: This brief review presents a comprehensive evaluation of valproate-induced encephalopathy (VHE) and also discusses potential mechanisms of the condition. SCOPE: Sodium valproate (VPA) is an effective antiepileptic drug used in neurology as well as in psychiatry, in adults and children. VHE requires early diagnosis and management. Focused research efforts in understanding the condition will help decrease its incidence. Delay in recognition of VHE can result in the development of potentially life-threatening complications.
FINDINGS: Management options are described. Since VPA frequently causes a modest rise in plasma ammonia levels which is asymptomatic, it is important to recognize the symptoms of VHE promptly and to correlate them with the plasma ammonia levels.
CONCLUSIONS: Although there are several case reports on VHE, this review is a comprehensive evaluation of its causes and potential mechanisms. Rapid diagnosis and management will help in reducing VHE-related morbidity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22587482     DOI: 10.1185/03007995.2012.694362

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  13 in total

1.  Encephalopathy induced by combination therapy with valproic Acid and topiramate: challenging the utility of serum ammonia measurement.

Authors:  Osric Sin; Josh Batterink
Journal:  Can J Hosp Pharm       Date:  2015 Jan-Feb

2.  Class I histone deacetylase inhibitor valproic acid reverses cognitive deficits in a mouse model of septic encephalopathy.

Authors:  Jing Wu; Lin Dong; Mingqiang Zhang; Min Jia; Guangfeng Zhang; Lili Qiu; Muhuo Ji; Jianjun Yang
Journal:  Neurochem Res       Date:  2013-09-26       Impact factor: 3.996

3.  Valproate-Induced Hyperammonemic Encephalopathy Following Accidental Ingestion in a Toddler.

Authors:  Moftah Alhagamhmad; Aisha Elarwah; Alia Alhassony; Shirin Alougly; Hamza Milad; Aziza Dehoam; Suliman Elbrgathy; Nuri Shembesh; Emhemed Mousa; Abdulhamid ElShiky
Journal:  J Pediatr Pharmacol Ther       Date:  2021-02-15

Review 4.  Valproate-Associated Parkinsonism: A Critical Review of the Literature.

Authors:  Florian Brugger; Kailash P Bhatia; Frank M C Besag
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

Review 5.  A Review of the Pharmacological and Clinical Profile of Newer Atypical Antipsychotics as Treatments for Bipolar Disorder: Considerations for Use in Older Patients.

Authors:  Akshya Vasudev; Sumit Chaudhari; Rickinder Sethi; Rachel Fu; Rachel M Sandieson; Brent P Forester
Journal:  Drugs Aging       Date:  2018-10       Impact factor: 3.923

6.  Increased Occurrence of Valproic Acid-Induced Hyperammonemia in Carriers of T1405N Polymorphism in Carbamoyl Phosphate Synthetase 1 Gene.

Authors:  Piotr K Janicki; Dmitri Bezinover; Marek Postula; Robert S Thompson; Jayant Acharya; Vinita Acharya; Cathy McNew; J Daniel Bowman; Iwona Kurkowska-Jastrzebska; Dagmara Mirowska-Guzel
Journal:  ISRN Neurol       Date:  2013-08-07

7.  Hypothyroidism may exacerbate valproate-related hyperammonemic delirium.

Authors:  Chung-Chieh Hung; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  Biomedicine (Taipei)       Date:  2016-05-09

Review 8.  Hyperammonemic coma after craniotomy: Hepatic encephalopathy from upper gastrointestinal hemorrhage or valproate side effect?: Case report and literature review.

Authors:  Xiaopeng Guo; Junji Wei; Lu Gao; Bing Xing; Zhiqin Xu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 9.  Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insights.

Authors:  John R Ostergaard
Journal:  Degener Neurol Neuromuscul Dis       Date:  2016-08-01

10.  Unusual cause of hyperammonemia in two cases with short-term and long-term valproate therapy successfully treated by single dose carglumic acid.

Authors:  Ciğdem Seher Kasapkara; Murat Kanğın; Funda Feryal Taş; Yasemin Topçu; Remezan Demir; Mehmet Nuri Ozbek
Journal:  J Pediatr Neurosci       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.